Personal information

No personal information available

Activities

Collapse all

Employment (3)

University of California San Diego Health Sciences: La Jolla, CA, US

1983-07 to 1984-06 | Clinical and Research Fellow (Endocrinology and Metabolism)
Employment
Source: Self-asserted source
W. Timothy Garvey

University of Colorado Denver School of Medicine: Aurora, CO, US

1982-01 to 1983-06 | Clinical and Research Fellowship (Endocrinology and Metabolism)
Employment
Source: Self-asserted source
W. Timothy Garvey

Barnes-Jewish Hospital: Saint Louis, MO, US

1978-07 to 1981-06 | Internship & Residency (Internal Medicine)
Employment
Source: Self-asserted source
W. Timothy Garvey

Education and qualifications (2)

Saint Louis University: Saint Louis, MO, US

1974-09 to 1978-06 | MD, cum laude (School of Medicine)
Education
Source: Self-asserted source
W. Timothy Garvey

Washington University in Saint Louis: Saint Louis, MO, US

1970-09 to 1974-06 | BA, summa cum laude
Education
Source: Self-asserted source
W. Timothy Garvey

Works (24)

The impact of a low‐carbohydrate (vs. low‐fat) diet on fat mass loss in African American women is modulated by insulin sensitivity

Obesity
2025-02 | Journal article
DOI: 10.1002/oby.24201
Contributors: Catia Martins; David R. Bryan; S. Katherine Sweatt; W. Timothy Garvey; Kevin R. Fontaine; Gareth R. Dutton; Barbara A. Gower
Source: check_circle
Crossref

A Focus on the Pharmacotherapy of Obesity

Diabetes Spectrum
2024-11-01 | Journal article
DOI: 10.2337/dsi24-0006
Contributors: W. Timothy Garvey
Source: check_circle
Crossref

Future Medications for Obesity and Clinical Implications

Diabetes Spectrum
2024-11-01 | Journal article
DOI: 10.2337/dsi24-0004
Contributors: W. Timothy Garvey
Source: check_circle
Crossref

Response to Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562–570

Diabetes Care
2024-09-01 | Journal article
DOI: 10.2337/dci24-0049
Contributors: W. Timothy Garvey; Robert M. Cohen
Source: check_circle
Crossref

Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP‐1, GIP receptor agonists, and dual agonists

Obesity Science & Practice
2024-06 | Journal article
DOI: 10.1002/osp4.756
Contributors: W. Timothy Garvey; Cathy D. Mahle; Trevor Bell; Robert F. Kushner
Source: check_circle
Crossref

Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial

Diabetes Care
2024-04-01 | Journal article
DOI: 10.2337/dc23-1782
Contributors: W. Timothy Garvey; Robert M. Cohen; Nicole M. Butera; Erin J. Kazemi; Naji Younes; Samuel P. Rosin; Colleen E. Suratt; Andrew Ahmann; Priscilla A. Hollander; Jonathan Krakoff et al.
Source: check_circle
Crossref

Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Diabetes Care
2024-04-01 | Journal article
DOI: 10.2337/dc23-1332
Contributors: M. Sue Kirkman; Mark Tripputi; Heidi Krause-Steinrauf; Ionut Bebu; Hiba AbouAssi; Henry Burch; Elizabeth Duran-Valdez; Hermes Florez; W. Timothy Garvey; Daniel S. Hsia et al.
Source: check_circle
Crossref

Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT‐1 trial

Diabetes, Obesity and Metabolism
2023-12 | Journal article
DOI: 10.1111/dom.15269
Contributors: Emily R. Hankosky; Hui Wang; Lisa M. Neff; Hong Kan; Fangyu Wang; Nadia N. Ahmad; Adam Stefanski; W. Timothy Garvey
Source: check_circle
Crossref

Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020

Journal of Medical Economics
2023-12-31 | Journal article
DOI: 10.1080/13696998.2023.2183679
Contributors: Nina Kim; Abdalla Aly; Chris Craver; W. Timothy Garvey
Source: check_circle
Crossref

Effect of semaglutide 2.4 mg once weekly on 10‐year type 2 diabetes risk in adults with overweight or obesity

Obesity
2023-09 | Journal article
DOI: 10.1002/oby.23842
Contributors: Lua Wilkinson; Thomas Holst‐Hansen; Peter N. Laursen; Anders R. Rinnov; Rachel L. Batterham; W. Timothy Garvey
Source: check_circle
Crossref

Associations Among Physical Activity, Adiposity, and Insulin Resistance in Children Exposed In Utero to Maternal Obesity With and Without Gestational Diabetes

Pediatric Exercise Science
2023-08-01 | Journal article
DOI: 10.1123/pes.2021-0222
Contributors: Bethany A. Moore; Makenzie L. Callahan; Samantha L. Martin; Alysha Everett; W. Timothy Garvey; Paula Chandler-Laney
Source: check_circle
Crossref

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

Nature Medicine
2022-10 | Journal article
DOI: 10.1038/s41591-022-02026-4
Contributors: W. Timothy Garvey; Rachel L. Batterham; Meena Bhatta; Silvio Buscemi; Louise N. Christensen; Juan P. Frias; Esteban Jódar; Kristian Kandler; Georgia Rigas; Thomas A. Wadden et al.
Source: check_circle
Crossref

Examining the evidence for weight management in individuals with type 2 diabetes

Diabetes, Obesity and Metabolism
2022-08 | Journal article
DOI: 10.1111/dom.14764
Contributors: W. Timothy Garvey; Guillermo E. Umpierrez; Julia P. Dunn; Anita Y. M. Kwan; Oralee J. Varnado; Manige Konig; Joshua A. Levine
Source: check_circle
Crossref

Associations between cardiometabolic disease severity, social determinants of health (SDoH), and poor COVID‐19 outcomes

Obesity
2022-07 | Journal article
DOI: 10.1002/oby.23440
Contributors: Carrie R. Howell; Li Zhang; Nengjun Yi; Tapan Mehta; Andrea L. Cherrington; W. Timothy Garvey
Source: check_circle
Crossref

New Horizons. A New Paradigm for Treating to Target with Second-Generation Obesity Medications

The Journal of Clinical Endocrinology & Metabolism
2022-03-24 | Journal article
DOI: 10.1210/clinem/dgab848
Contributors: W Timothy Garvey
Source: check_circle
Crossref

Is Obesity or Adiposity-Based Chronic Disease Curable: The Set Point Theory, the Environment, and Second-Generation Medications

Endocrine Practice
2022-02 | Journal article
DOI: 10.1016/j.eprac.2021.11.082
Contributors: W. Timothy Garvey
Source: check_circle
Crossref

Long‐term health benefits of intensive lifestyle intervention in the Look AHEAD study

Obesity
2021-08 | Journal article
DOI: 10.1002/oby.23198
Contributors: W. Timothy Garvey
Source: check_circle
Crossref

Diagnosing Obesity as a First Step to Weight Loss: An Observational Study

Obesity
2020-12 | Journal article
DOI: 10.1002/oby.22954
Contributors: Elizabeth L. Ciemins; Vaishali Joshi; John K. Cuddeback; Robert F. Kushner; Deborah B. Horn; W. Timothy Garvey
Source: check_circle
Crossref

Response to “The Future of Obesity Diagnostic Coding”

Obesity
2020-07 | Journal article
DOI: 10.1002/oby.22815
Contributors: W. Timothy Garvey; Jeffrey I. Mechanick
Source: check_circle
Crossref

Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5

Obesity
2020-06 | Journal article
DOI: 10.1002/oby.22794
Contributors: Robert F. Kushner; Salvatore Calanna; Melanie Davies; Dror Dicker; W. Timothy Garvey; Bryan Goldman; Ildiko Lingvay; Mette Thomsen; Thomas A. Wadden; Sean Wharton et al.
Source: check_circle
Crossref

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

Diabetes Care
2020-05-01 | Journal article
DOI: 10.2337/dc19-1745
Contributors: W. Timothy Garvey; Andreas L. Birkenfeld; Dror Dicker; Geltrude Mingrone; Sue D. Pedersen; Altynai Satylganova; Dorthe Skovgaard; Danny Sugimoto; Camilla Jensen; Ofri Mosenzon
Source: check_circle
Crossref

Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity

Obesity
2020-03 | Journal article
DOI: 10.1002/oby.22727
Contributors: W. Timothy Garvey; Jeffrey I. Mechanick
Source: check_circle
Crossref

Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study

Diabetes Care
2019-06-01 | Journal article
DOI: 10.2337/dc18-2388
Contributors: Aksam Yassin; Ahmad Haider; Karim S. Haider; Monica Caliber; Gheorghe Doros; Farid Saad; W. Timothy Garvey
Source: check_circle
Crossref

Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release

Diabetes Care
2017-07-01 | Journal article
DOI: 10.2337/dc17-0088
Contributors: Fangjian Guo; W. Timothy Garvey
Source: check_circle
Crossref

Peer review (3 reviews for 3 publications/grants)

Review activity for Nature medicine. (1)
Review activity for Pharmacological Reports. (1)
Review activity for The journal of clinical endocrinology and metabolism. (1)
How many people are using ORCID?